Adult stem cell therapy begins human trial
For the first time in humans a doctor has extracted adult stem cells from fat tissue and injected them directly into the heart as a therapy for angina and heart disease. Physicians in Spain--working with investigators at the Texas Heart Institute in Houston--say that it will be at least six months before they can determine if the therapy is working. Another 35 volunteers suffering from chronic myocardial ischemia, a severe form of end-stage coronary artery disease, will be given the therapy developed by Cytori Therapeutics. In preclinical tests the therapy spurred improved circulation in the heart.
"Patients with chronic heart disease today have few options making this an important milestone for the affected patients and doctors that treat them," said Marc H. Hedrick, M.D., president for Cytori Therapeutics. "This study is designed to show unequivocally whether the cells from our Celution System can be safely introduced into the heart."
- see the release on the trial
Related Articles:
New study to use stem cells after heart attacks. Report
Heart muscle created from embryonic stem cells. Report
Scientists grow new heart valves from stem cells. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


